Japanese pharmaceutical firm Eisai has secured approval from the European Commission (EC) on the license extension application for the use of antiepileptic agent Zonegran (zonisamide) in the treatment of pediatric patients. The EC ...
Tags: Eisai Obtains, Zonegran
The US Food & Drug Administration (cof Orphan Product Development has granted orphan drug designation for Lumena Pharmaceuticals' LUM001 clinical program. Lumena obtained orphan designation for LUM001 in four rare cholestatic liver ...
Tags: Orphan Drug, Rare Liver Diseases
The US Food and Drug Administration (FDA) has granted more than $3.5m to various pediatric device consortia to encourage the development and availability of medical devices for children. This grants program is administered by the FDA's ...
Tags: Pediatric Medical Device, Medicine
Kyowa Hakko Kirin, a pharmaceutical company, has received the Japanese approval for manufacturing and marketing the NESP injection 5μg plastic syringe as an additional formulation in Japan. NESP is a long-acting erythropoiesis ...
Tags: Plastic Syringe, Kyowa Hakko Kirin
British drugmaker AstraZeneca has received positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for its new four-in-one flu vaccine Fluenz Tetra. Fluenz Tetra, a nasally ...
Tags: Astrazeneca, Medicine
Biotechnology firm Alexion Pharmaceuticals has secured approval from the Ministry of Health, Labour and Welfare (MHLW) in Japan for the use of its Soliris (eculizumab) drug to treat pediatric and adult patients with atypical hemolytic ...
Tags: Ahus Treatment, Soliris Drug
Plexcera Therapeutics has received approval from Mount Sinai Innovation Partners (MSIP), part of the Icahn School of Medicine, to develop recombinant human acid ceramidase (rhAC) for treatment of diseases caused by genetic or ...
Tags: Plexcera, Cystic Fibrosis
The Bill & Melinda Gates Foundation has granted $1.15m funding to a global public-private partnership (PPP), to develop a new pediatric formulation to fight schistosomiasis, commonly known as bilharzia, in preschool children. Formed in ...
Tags: Schistosomiasis Drug, Medicine
The US FDA has approved Silvergate Pharmaceuticals' Epaned (enalapril maleate Powder for Oral Solution) to treat hypertension (high blood pressure) in people aged one month and more. Silvergate Pharmaceuticals president and CEO Frank ...
The US Food and Drug Administration (FDA) has expanded age indication for Novartis' Menveo (Meningococcal [Groups A, C, Y and W-135] Oligosaccharide Diphtheria CRM197 Conjugate Vaccine) to include infants and toddlers aged two months and ...
Sofi Insurance Services is planning to offer comprehensive insurance plans under the Affordable Care Act for small employers. As per the Affordable Care Act, it is mandatory for most of the Americans to have adequate health coverage ...
The American Institute of Architects (AIA) Academy of Architecture for Health (AAH) has selected the recipients of the AIA National Healthcare Design Awards program. The AIA Healthcare Awards program showcases the best of healthcare ...
Tags: Lights, Lighting, Construction
US-based Medtronic has introduced its CD Horizon Solera Spinal System Sagittal Adjusting Screw (SAS), which could be used in the surgical correction of complex spinal conditions. The SAS system is the company's fifth-generation spinal ...
Tags: Medtronic, Spinal Conditions
US-based organic, kids nutrition firm Plum Organics has unveiled a range of organic pouch snacks for toddlers - Mighty 4. The new Mighty 4 is available in 5 food combinations, including Sweet Potato, Blueberry, Millet, Greek Yogurt; Kale, ...
Tags: Plum Organics, Pouch Snacks
The FDA has approved the use of Astellas Pharma US' Mycamine (micafungin sodium) for injection to treat pediatric patients aged four months and more with candidemia, acute disseminated candidiasis, Candida peritonitis and abscesses, ...